Neurogenic and Myogenic Diseases: Quantitative Texture Analysis of Muscle US Data for Differentiation.

Purpose To assess the multiple texture features of skeletal muscles in neurogenic and myogenic diseases by using ultrasonography (US). Materials and Methods After institutional review board approval, muscle US studies of the medial head of the gastrocnemius were performed prospectively in patients with neurogenic diseases (n = 25 [18 men]; mean age, 66.0 years ± 12.3 [standard deviation]), in patients with myogenic diseases (n = 21 [12 men]; mean age, 68.3 years ± 11.5), and in healthy control subjects (n = 21 [11 men]; mean age, 70.5 years ± 8.4) between January 2013 and May 2016. Written informed consent was obtained. Muscle texture parameters were obtained, and five algorithms were used to classify the groups. Results The neurogenic and myogenic disease groups showed higher echo intensities than the control subjects. The histogram-derived texture parameters had overlaps between the neurogenic and myogenic groups and thus had a low discrimination rate. With assessment of more classes of texture parameters, three groups were correctly classified (100% correct, according to four of five classification algorithms). Tenfold cross validation showed 93.5%-95.7% correct classification between the neurogenic and myogenic groups. The run-length matrix, autoregressive model, and co-occurrence matrix were particularly useful in distinguishing the neurogenic and myogenic groups. Conclusion Texture analysis of muscle US data can enable differentiation between neurogenic and myogenic diseases and is useful in noninvasively assessing underlying disease mechanisms. © RSNA, 2017 Online supplemental material is available for this article.

[1]  C. Zaidman,et al.  Quantitative muscle ultrasound in Duchenne muscular dystrophy: A comparison of techniques , 2015, Muscle & nerve.

[2]  S Leeman,et al.  Ultrasound imaging in the diagnosis of muscle disease. , 1982, The Journal of pediatrics.

[3]  R. Kaji,et al.  Intramuscular dissociation of echogenicity in the triceps surae characterizes sporadic inclusion body myositis , 2016, European journal of neurology.

[4]  M. Rose,et al.  International Workshop : Inclusion Body Myositis , 2 – 4 December 2011 , Naarden , The Netherlands , 2013 .

[5]  U. Bogdahn,et al.  Real‐time sonography of acute and chronic muscle denervation , 1991, Muscle & nerve.

[6]  S. Pillen,et al.  Quantitative muscle ultrasonography in amyotrophic lateral sclerosis. , 2008, Ultrasound in medicine & biology.

[7]  D. Pongratz,et al.  Skeletal muscle sonography: a correlative study of echogenicity and morphology , 1993, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[8]  A. Ludolph,et al.  Quantitative muscle ultrasound in neuromuscular disorders using the parameters ‘intensity’, ‘entropy’, and ‘fractal dimension’ , 2009, European journal of neurology.

[9]  H. Axer,et al.  Muscle ultrasonography as an additional diagnostic tool for the diagnosis of amyotrophic lateral sclerosis , 2015, Clinical Neurophysiology.

[10]  R. Hughes,et al.  119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands , 2004, Neuromuscular Disorders.

[11]  Filippo Molinari,et al.  Advances in quantitative muscle ultrasonography using texture analysis of ultrasound images. , 2015, Ultrasound in medicine & biology.

[12]  Gabriela Castellano,et al.  Texture analysis of magnetic resonance images of patients with juvenile myoclonic epilepsy , 2013, Epilepsy & Behavior.

[13]  Zixiang Xiong,et al.  Optimal number of features as a function of sample size for various classification rules , 2005, Bioinform..

[14]  Klaus D. Tönnies,et al.  Ultrasound texture-based CAD system for detecting neuromuscular diseases , 2015, International Journal of Computer Assisted Radiology and Surgery.

[15]  D. Cornblath,et al.  Assessment of current diagnostic criteria for Guillain‐Barré syndrome , 1990, Annals of neurology.

[16]  Sabrina Paganoni,et al.  Electrodiagnostic evaluation of myopathies. , 2013, Physical medicine and rehabilitation clinics of North America.

[17]  J. H. van der Hoeven,et al.  Muscle ultrasound analysis: normal values and differentiation between myopathies and neuropathies. , 2003, Ultrasound in medicine & biology.

[18]  M. Swash,et al.  Electrodiagnostic criteria for diagnosis of ALS , 2008, Clinical Neurophysiology.

[19]  M. Weber Ultrasound in the Inflammatory Myopathies , 2009, Annals of the New York Academy of Sciences.